Tofacitinib is Effective in Treating Refractory Immune Checkpoint Inhibitor Hepatitis

被引：3
|
作者：
Wang, Mike [1 ,2 ]
Reynolds, Kerry L. [1 ,2 ]
Montazeri, Kamaneh [1 ,2 ]
Schaefer, Esperance A. [2 ,3 ]
Sullivan, Ryan J. [1 ,2 ]
Dougan, Michael [2 ,3 ]
机构：
[1] Massachusetts Gen Hosp, Mass Gen Canc Ctr, Boston, MA 02114 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA USA
来源：
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | 2024年 / 22卷 / 07期
关键词：
D O I：
10.1016/j.cgh.2023.12.011
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1539 / 1541
页数：3
相关论文
共 50 条
  • [1] Tofacitinib for the treatment of refractory immune checkpoint inhibitor-associated immune nephritis
    Shivaraj, Kiran
    Tchakarov, Amanda
    Dong, Yanlan
    Lin, Jamie S.
    CLINICAL KIDNEY JOURNAL, 2024, 17 (05)
  • [2] PREDICTORS AND OUTCOMES OF STEROID-REFRACTORY IMMUNE CHECKPOINT INHIBITOR HEPATITIS
    Li, Michael
    Sack, Jordan
    Rahma, Osama E.
    Grover, Shilpa
    Zucker, Stephen D.
    HEPATOLOGY, 2020, 72 : 85A - 85A
  • [3] Efficacy and Outcome of Tofacitinib in Immune checkpoint Inhibitor Colitis
    Bishu, Shrinivas
    Melia, Joanna
    Sharfman, William
    Lao, Christopher D.
    Fecher, Leslie A.
    Higgins, Peter D. R.
    GASTROENTEROLOGY, 2021, 160 (03) : 932 - +
  • [4] Case Report: A severe case of immunosuppressant-refractory immune checkpoint inhibitor-mediated colitis rescued by tofacitinib
    Sweep, Mark W. D.
    Tjan, Martijn J. H.
    Gorris, Mark A. J.
    Bol, Kalijn F.
    Westdorp, Harm
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [5] Vedolizumab Treatment of Refractory Immune Checkpoint Inhibitor Colitis
    McNally, Bridgette B.
    Sivakumar, Angiela
    Haddad, Nael
    Suchartlikitwong, Sakolwan
    Aguon, Paul Muna
    Fung, Brian M.
    Zucker, Kelly
    David, Joseph
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S756 - S756
  • [6] Biologic Therapy for Refractory Immune Checkpoint Inhibitor Colitis
    Alorfi, Nasser M.
    Alourfi, Mansour Marzouq
    BIOLOGICS-TARGETS & THERAPY, 2022, 16 : 119 - 127
  • [7] First use of tofacitinib to treat an immune checkpoint inhibitor-induced arthritis
    Murray, Kieran
    Floudas, Achilleas
    Murray, Ciara
    Fabre, Aurelie
    Crown, John
    Fearon, Ursula
    Veale, Douglas
    BMJ CASE REPORTS, 2021, 14 (02)
  • [8] The role of the microbiome in immune checkpoint inhibitor colitis and hepatitis
    Ryan, Thomas
    Ling, Sophia
    Trinh, Andrew
    Segal, Jonathan P.
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2024, 72
  • [9] Immune Checkpoint Inhibitor-Associated Colits and Hepatitis
    Reddy, Haritha G.
    Schneider, Bryan J.
    Tai, Andrew W.
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2018, 9
  • [10] Severe Immune Checkpoint Inhibitor Hepatitis: Case Report
    Aliyev, Nurlan
    Chaisidhivej, Natapat
    Reif, Meagan S.
    Bhat, Romana A.
    Khoury, Nathalie
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S2894 - S2895
12345